Silvia Stotani

Silvia Stotani graduated with first class honors in Medicinal Chemistry in 2012 from the University of Rome (Italy). While working as a Quality Control chemist for Baxter in Rieti (Italy), she started a second level master in “Design and development of drugs” at the University of Pavia (Italy). For her master project she joined the Drug Design Department of Professor Dömling at the University of Groningen (The Netherlands), were she spent 5 months as a master student and other 6 months as research assistant. She is currently a PhD student at Taros GmbH, in Dortmund (Germany) for the European Marie Curie Integrate ETN project in antibacterial drug discovery.

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska Curie grant agreement No  642620
European Union